Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 111 participants.
Also called NCT06439758
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 111 participants
- Sponsor
- Registry
-
NCT06439758
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06439758. Randomized; double masking; primary purpose treatment. Start 2024-08-01 (anticipated); primary completion 2025-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes
- Condition
- Diabetes Type 2
- Condition
- Osteoporosis
- Intervention (Drug)
- Metformin
- Intervention (Behavioral)
- Lifestyle
- Lead sponsor
- King Saud University
Record details
- Record id
cardio:ct-nct06439758- Content hash
256f4d5be3607033634e7418896d7173115fd8b5789d57b29e4b1fdbb1ce2ba7